Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injury

Published:2020-10 Issue:4 Volume:531 Page:622-627
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Yanagida Yosuke,Namba Mio,Fukuta Tatsuya,Yamamoto Hirokazu,Yanagida Mitsuaki,Honda Miki,Oku Naoto,Asai Tomohiro

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference24 articles.

1. Neuroprotection for ischemic stroke: past, present and future;Ginsberg;Neuropharmacology,2008

2. Rock-Als: Protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the Rho kinase (ROCK) inhibitor fasudil in amyotrophic lateral sclerosis;Lingor;Front. Neurol.,2019

3. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase;McGown;Microvasc. Res.,2011

4. Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway;Li;PLoS One,2018

5. Fasudil protects cultured N1E-115 cells against lysophosphatidic acid-induced neurite retraction through inhibition of Rho-kinase;Satoh;Brain Res. Bull.,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system;Frontiers in Immunology;2023-03-09

2. Enhancement of cerebroprotective effects of lipid nanoparticles encapsulating FK506 on cerebral ischemia/reperfusion injury by particle size regulation;Biochemical and Biophysical Research Communications;2022-06

3. Biomimetic Nanoparticle Drug Delivery Systems to Overcome Biological Barriers for Therapeutic Applications;Chemical and Pharmaceutical Bulletin;2022-05-01

4. Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke;Pharmaceutics;2022-02-04

5. Liposome Assisted Drug Delivery-An Updated Review;Indian Journal of Pharmaceutical Sciences;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3